Ambu's revenues and earnings disappoint despite top-line growth

Growth in the second quarter is a little weaker than the consensus estimate, while the Danish medtech company’s profit has seen a sharp year-over-year drop. 
Photo: Ambu/pr
Photo: Ambu/pr
by marketwire, translated by daniel pedersen

Despite a growing top line, Ambu’s second-quarter growth in financial year 2022/2023 looks a little weaker than what analysts had anticipated, for example sliding back from the profit of the same quarter a year before. 

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading